HAYA To Complement Lilly’s Metabolic Disease Efforts With Long Non-Coding RNA

 
• By Joseph Haas
  
Dark genome
HAYA is partnering with Lilly on dark genome-derived therapies • Source: Shutterstock

More from Deals

More from Business